Tempus AI news and events in 2026
Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data. We enable physicians to make real-time, data-driven decisions to deliver personalized care and targeted therapies for patients through our analytical machine...
Public (TEM)Biotechnology Research5,001 to 10,000 employeestempus.comLinkedIn
- Dated updates
- 92
- Last event
- Sep 29, 2026
- Open rolesSnapshot Sep 29, 2026
- 40
- Latest SEC filing
- Jul 30, 2026
Overview
Tempus AI by topic
110-K filing
40open roles
1executive move
67+signals
38 in the last 90 days
- Glassdoor15+
- LinkedIn15+
- Website changes15+
- YouTube12
- and 2 more sources
Latest events
Latest Tempus AI events
Showing 10 of 19 events. The Signal API returns all of them.
Get them with one API call- News
- In developmentTempus AI (TEM) Unveils Whole Genome Platform With Plans For 1 Million GenomesAnnounced a new whole-genome sequencing initiative and platform linked to clinical data for AI research, with general availability planned for mid-2027.
- LaunchTempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGsWith U.S. Food and Drug Administration
- RevenueTempus AI posts first GAAP profit, boosts 2026 revenue forecast to $1.6B with FDA approval aiding growthTempus AI raised its 2026 revenue forecast to between $1.595 billion and $1.605 billion.
- AwardTempus AI's FDA Win Could Unlock Major Reimbursement Growth AheadWith Food and Drug Administration
- In developmentTempus AI's FDA Win Could Unlock Major Reimbursement Growth AheadWith U.S. Food and Drug Administration
- EarningsIs Tempus AI Worth Buying as Growth Improves but Valuation Stays High?Tempus AI reported a second-quarter GAAP net income of $5.6 million.
- PartnershipCellCarta Adds Tempus to CDx Commercialization Lab NetworkTempus AI has joined CellCarta's CDx Commercialization Lab Network as its second commercial laboratory partner to support oncology-focused access.
- Acquisition
- Executive hireKelli Teno-Manalli joins Tempus AI as Vice President, Head of Communications.Kelli Teno-Manalli, Vice President, Head of Communications
Showing 10 of 19 events. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Tempus AI with the Signal API
One POST /v1/companies/enrich call with tempus.com returns every signal type for Tempus AI, each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"tempus.com","limit":20}'Same industry
Companies related to Tempus AI
Tempus AI questions
What is the latest news on Tempus AI?
What is going on with Tempus AI?
Has Tempus AI announced any acquisitions?
What else does Autobound track for Tempus AI?
Is Tempus AI hiring right now?
Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.
Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.
Data as of .